Innate Pharma

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-06-30
Revenue
$6,172
$10,721
$6,172
$10,721
Gross Profit
-8,365
-1,563
-8,365
-1,563
EBITDA
-12,781
-5,198
-12,781
-5,198
EBIT
-13,156
-6,135
-13,156
-6,135
Net Income
-12,382
-4,644
-12,382
-4,644
Net Change In Cash
6,172
10,721
6,172
10,721
Free Cash Flow
1,376
-10,567
1,376
-10,567
Cash
69,990
70,605
69,990
70,605
Basic Shares
80,872
80,586
80,872
80,586

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$51,901
$49,639
$12,112
$56,833
Gross Profit
-4,121
-2,024
-34,892
53,791
EBITDA
-1,839
-57,425
-43,229
13,305
EBIT
-6,930
-61,849
-47,798
3,920
Net Income
-7,570
-99,103
-59,136
-70,747
Net Change In Cash
51,901
49,639
12,112
56,833
Free Cash Flow
-34,909
-20,276
-59,787
-63,089
Cash
70,605
84,225
103,756
136,792
Basic Shares
80,453
79,639
79,542
78,934

Earnings Calls

Quarter EPS
2024-03-31
$0
2023-12-31
$0
2023-09-30
$0
2023-06-30
$0.02